Evidence map›Paper›PMID 28718077›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients.

Adam Ali Ghotbi, Philip Hasbak, Lars Nepper-Christensen, Jacob Lønborg, Kiril Atharovski, Thomas Christensen, Lene Holmvang, Thomas Engstrøm, Rasmus Sejersten Ripa, Andreas Kjær

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Positron emission tomography, computed tomography and magnetic resonance.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Review
  3. Early post-STEMI PET, a judicious investment?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Adam Ali GhotbiDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark. adamghotbi@gmail.com.
Philip HasbakDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Lars Nepper-ChristensenDepartment of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.
Jacob LønborgDepartment of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.
Kiril AtharovskiDepartment of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.
Thomas ChristensenDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Lene HolmvangDepartment of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.
Thomas EngstrømDepartment of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.
Rasmus Sejersten RipaDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Andreas KjærDepartment of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Rigshospitalet · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAssessment of infarct size after myocardial infarction is predictive of subsequent morphological changes and clinical outcome. This study aimed to assess subacute post-intervention Rubidium-82 (

methodsSTEMI patients undergoing percutaneous coronary intervention were included prospectively. Rest-only

results42 patients were included, but only 35 had follow-up CMR and constituted the study population. Absolute blood flow was significantly lower in the infarct-related territory compared to remote myocardium, P < .005. Extent of hypoperfusion correlated with final infarct size, r = 0.58, P < .001, while blood flow correlated with ejection fraction, r = 0.41, P < .05. In linear mixed models, higher subacute absolute blood flow (β = 4.6, confidence interval [3.5; 5.2], P < .001, R

conclusionsSubacute rest-only

Indexed as

Positron-Emission TomographyRisk AssessmentRubidium RadioisotopesAgedContrast MediaFemaleGadoliniumHumansLinear ModelsMaleMiddle AgedPerfusionPredictive Value of TestsProspective StudiesSoftwareST Elevation Myocardial InfarctionContrast MediaGadoliniumRubidium-82Rubidium Radioisotopescardiac magnetic resonancefinal infarct sizemyocardial blood flowPositron emission tomographyRubidium-82ST-segment elevation myocardial infarction

Identifiers

PMID28718077
PMCPMC6430746
OpenAlexW2736258116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.